Medroxyprogesterone acetate injectable recalls
The FDA has published 9 recalls involving Medroxyprogesterone acetate injectable since 2021. The latest was reported on 7 May 2025. Most were for sterility. Sun Pharmaceutical Industries has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.
Total recalls9since 2021
Last 12 months0reported
Class I00% of total
Ongoing1latest 7 May 2025
Recalls per month, last 24 months
click a bar for that monthSeverity split
Class I 0 0%Class II 9 100%Class III 0 0%
Why medroxyprogesterone acetate injectable is recalled
Companies
By year
Ongoing medroxyprogesterone acetate injectable recalls
1 active| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Medroxyprogesterone Acetate Injectable Suspension recalled | Mckesson Medical-Surgical Inc. Corporate Office | Potency & Assay | FL, MS |
All medroxyprogesterone acetate injectable recalls, newest first
9 totalShould you stop taking Medroxyprogesterone acetate injectable?
Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.